Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe Locations section now lists many new study sites across the United States, Australia, Canada, Hong Kong, India, Japan, and other regions, broadening the geographic footprint of the trial.SummaryDifference2%

- Check51 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the page.SummaryDifference0.0%

- Check58 days agoChange DetectedEditorial refinements were made to the Publications section to clarify that some publications are entered voluntarily and that others are automatically filled from PubMed, and the revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page removed a government funding/operational status notice related to NIH operations; this change does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedAdded the Study Results section with linked publications and updated results dates, including the NEJM 2024 publication.SummaryDifference0.2%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.